Literature DB >> 17284606

Acute postnatal ablation of Hif-2alpha results in anemia.

Michaela Gruber1, Cheng-Jun Hu, Randall S Johnson, Eric J Brown, Brian Keith, M Celeste Simon.   

Abstract

Adaptive transcriptional responses to oxygen deprivation (hypoxia) are mediated by the hypoxia-inducible factors (HIFs), heterodimeric transcription factors composed of two basic helix-loop-helix-PAS family proteins. The transcriptional activity of HIF is determined by the hypoxic stabilization of the HIF-alpha proteins. HIF-1alpha and HIF-2alpha exhibit high sequence homology but have different mRNA expression patterns; HIF-1alpha is expressed ubiquitously whereas HIF-2alpha expression is more restricted to certain tissues, e.g., the endothelium, lung, brain, and neural crest derivatives. Germ-line deletion of either HIF subunit is embryonic lethal with unique features suggesting important roles for both HIF-alpha isoforms. Global deletion of Hif-2alpha results in distinct phenotypes depending on the mouse strain used for the mutation, clearly demonstrating an important role for HIF-2alpha in mouse development. The function of HIF-2alpha in adult life, however, remains incompletely understood. In this study, we describe the generation of a conditional murine Hif-2alpha allele and the effect of its acute postnatal ablation. Under very stringent conditions, we ablate Hif-2alpha after birth and compare the effect of acute global deletion of Hif-2alpha and Hif-1alpha. Our results demonstrate that HIF-2alpha plays a critical role in adult erythropoiesis, with acute deletion leading to anemia. Furthermore, although HIF-1alpha was first purified and cloned based on its affinity for the human erythropoietin (EPO) 3' enhancer hypoxia response element (HRE) and regulates Epo expression during mouse embryogenesis, HIF-2alpha is the critical alpha isoform regulating Epo under physiologic and stress conditions in adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284606      PMCID: PMC1892942          DOI: 10.1073/pnas.0608382104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.

Authors:  R Feil; J Wagner; D Metzger; P Chambon
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

4.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

Authors:  N V Iyer; L E Kotch; F Agani; S W Leung; E Laughner; R H Wenger; M Gassmann; J D Gearhart; A M Lawler; A Y Yu; G L Semenza
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

5.  Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.

Authors:  E Maltepe; J V Schmidt; D Baunoch; C A Bradfield; M C Simon
Journal:  Nature       Date:  1997-03-27       Impact factor: 49.962

6.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor.

Authors:  R K Jain; N Safabakhsh; A Sckell; Y Chen; P Jiang; L Benjamin; F Yuan; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development.

Authors:  H Tian; R E Hammer; A M Matsumoto; D W Russell; S L McKnight
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

8.  The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice.

Authors:  Marzia Scortegagna; Margaret A Morris; Yavuz Oktay; Michael Bennett; Joseph A Garcia
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

9.  Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice.

Authors:  Veerle Compernolle; Koen Brusselmans; Till Acker; Peter Hoet; Marc Tjwa; Heike Beck; Stéphane Plaisance; Yuval Dor; Eli Keshet; Florea Lupu; Benoit Nemery; Mieke Dewerchin; Paul Van Veldhoven; Karl Plate; Lieve Moons; Désiré Collen; Peter Carmeliet
Journal:  Nat Med       Date:  2002-06-10       Impact factor: 53.440

10.  Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.

Authors:  Christian Rosenberger; Stefano Mandriota; Jan Steffen Jürgensen; Michael S Wiesener; Jan H Hörstrup; Ulrich Frei; Peter J Ratcliffe; Patrick H Maxwell; Sebastian Bachmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

View more
  219 in total

1.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

3.  Inducible glomerular erythropoietin production in the adult kidney.

Authors:  Katharina Gerl; Lucile Miquerol; Vladimir T Todorov; Christian P M Hugo; Ralf H Adams; Armin Kurtz; Birgül Kurt
Journal:  Kidney Int       Date:  2015-09-23       Impact factor: 10.612

Review 4.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

5.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.

Authors:  Michele M Hickey; Jennifer C Lam; Natalie A Bezman; W Kimryn Rathmell; M Celeste Simon
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Stress-associated erythropoiesis initiation is regulated by type 1 conventional dendritic cells.

Authors:  Taeg S Kim; Mark Hanak; Paul C Trampont; Thomas J Braciale
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

7.  A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.

Authors:  Felipe R Lorenzo; Chunzhang Yang; Mark Ng Tang Fui; Hariprasad Vankayalapati; Zhengping Zhuang; Thanh Huynh; Mathis Grossmann; Karel Pacak; Josef T Prchal
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

8.  Targeted deletion of Vegfa in adult mice induces vision loss.

Authors:  Toshihide Kurihara; Peter D Westenskow; Stephen Bravo; Edith Aguilar; Martin Friedlander
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

9.  Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

Authors:  Bing Zhou; Jeffrey S Damrauer; Sean T Bailey; Tanja Hadzic; Youngtae Jeong; Kelly Clark; Cheng Fan; Laura Murphy; Cleo Y Lee; Melissa A Troester; C Ryan Miller; Jian Jin; David Darr; Charles M Perou; Ross L Levine; Maximilian Diehn; William Y Kim
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

10.  Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function.

Authors:  Laura E Crotty Alexander; Kathryn Akong-Moore; Stephanie Feldstein; Per Johansson; Anh Nguyen; Elisa K McEachern; Shari Nicatia; Andrew S Cowburn; Joshua Olson; Jae Youn Cho; Hart Isaacs; Randall S Johnson; David H Broide; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-12-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.